Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTA) Operating Expenses (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed Operating Expenses for 7 consecutive years, with -$82.8 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 10.52% to -$82.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $109.7 million through Dec 2025, changed 0.04% year-over-year, with the annual reading at $63.5 million for FY2025, 21.81% up from the prior year.
  • Operating Expenses for Q4 2025 was -$82.8 million at Strata Critical Medical, down from $54.9 million in the prior quarter.
  • The five-year high for Operating Expenses was $83.1 million in Q4 2023, with the low at -$82.8 million in Q4 2025.
  • Average Operating Expenses over 5 years is $29.0 million, with a median of $41.7 million recorded in 2022.
  • The sharpest move saw Operating Expenses soared 18597.72% in 2021, then plummeted 190.16% in 2024.
  • Over 5 years, Operating Expenses stood at -$9.0 million in 2021, then grew by 2.44% to -$8.8 million in 2022, then surged by 1048.54% to $83.1 million in 2023, then crashed by 190.16% to -$74.9 million in 2024, then decreased by 10.52% to -$82.8 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at -$82.8 million, $54.9 million, and $75.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.